Showing 5351-5360 of 5771 results for "".
- Study: Glaukos iStent inject Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burdenhttps://modernod.com/news/study-glaukos-istent-inject-implantation-with-concomitant-cataract-surgery-provides-sustained-reduction-in-iop-and-medication-burden/2479620/Glaukos announced that a single-site international study of glaucoma subjects recently published in Ophthalmology and Therapy showed that the iStent inject Trabecular Micro-Bypass System, combined with cataract surgery, achieved a 37% reduction in mean IOP to 14.3 mmHg after 3 years of f
- SECO International Partners With the American Society of Optometric Surgeons for SECO 2019https://modernod.com/news/seco-international-partners-with-the-american-society-of-optometric-surgeons-for-seco-2019/2479621/SECO International has announced that SECO, the educational conference providing ophthalmic professionals educational opportunities since 1924, has partnered with the American Society of Optometric Surgeons (ASOS) to bring hands-on demonstrations showing radiosurgical technology, Botox, and YAG l
- Opternative Changes Names to Visibly To Better Reflect Eye Care Industry Partnershipshttps://modernod.com/news/opternative-changes-names-to-visibly-to-better-reflect-eye-care-industry-partnerships/2479622/Opternative announced that it has changed its name Visibly to better represent the eye care industry, according to a company news release. “We understand that our previous company name, Opternative, carried a negative connotation in the eye care industry and positioned the brand as a
- Anthem Blue Cross Blue Shield Now Covering Avedro’s Corneal Cross-Linking Procedurehttps://modernod.com/news/anthem-blue-cross-blue-shield-now-covering-avedros-corneal-cross-linking-procedure/2479624/Avedro announced that Anthem, the largest member of the Blue Cross Blue Shield Association, has issued a positive coverage policy for Avedro’s FDA-approved corneal cross-linking procedure bringing the total number of
- Federal Trade Commission Penalizes Online Sellers for Violating Contact Lens Rule, Bans Them from Selling Lenses in Futurehttps://modernod.com/news/federal-trade-commission-penalizes-online-sellers-for-violating-contact-lens-rule-bans-them-from-selling-lenses-in-future/2476152/The Healthcare Alliance for Patient Safety released a statement following yesterday’s announcement from the Federal Trade Commission (FTC)
- Clearside Presents Additional Analyses of PEACHTREE Clinical Trial Data in Support of Xipere in Treating Uveitic Macular Edemahttps://modernod.com/news/clearside-presents-additional-analyses-of-peachtree-clinical-trial-data-in-support-of-xipere-in-treating-uveitic-macular-edema/2476155/Clearside Biomedical recently announced that additional data from PEACHTREE, the company’s pivotal phase 3 trial of Xipere (formerly suprachoroidal CLS-TA) in patients with uveitic macular edema, were presented by Rahul N. Khurana, MD, Vitreoretinal Surgeon at Northern California
- Bausch + Lomb Receives FDA Clearance For Ultra Multifocal For Astigmatism Contact Lenseshttps://modernod.com/news/bausch-lomb-receives-fda-clearance-for-ultra-multifocal-for-astigmatism-contact-lenses/2476156/Bausch + Lomb announced that it has received FDA 510(k) clearance for Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses, the company’s first multifocal toric lens to be available as a standard offering. Bausch + Lomb says the monthly silicone hydrogel lens is the company&
- Nidek Launches Feedback Exam for Low Vision Care and Scotopic Microperimetryhttps://modernod.com/news/nidek-launches-feedback-exam-for-low-vision-care-and-scotopic-microperimetry/2479628/Nidek has announced the launch of the feedback exam for visual rehabilitation and scotopic microperimetry for the MP-3 Microperimeter. The MP-3 measures local retinal sensitivity for functional assessment of th
- Alcon’s Phaco Development (PD) Program Celebrates 10 Yearshttps://modernod.com/news/alcons-phaco-development-pd-program-celebrates-10-years/2476164/The Phaco Development (PD) program, an initiative between Alcon and specialist training institutes that builds cataract surgical capabilities across Asia and Russia, is celebrating its 10th anniversary this year. Over th
- Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Studyhttps://modernod.com/news/eyenovia-completes-patient-enrollment-in-microstat-mist-1-study-and-enrolls-first-patient-in-mist-2-study/2476167/Eyenovia announced that it has completed patient enrollment in its phase 3 MIST-1 study and enrolled the first patient in its second phase 3 study, the MIST-2 trial, for the company’s phase 3 MicroStat program for pharmacologic mydriasis. “We are pleased to